Skip Navigation

Strengthening the evidence for maternal and child health programs

Find Established Evidence


Displaying records 1 through 3 (3 total).

Dorrington MS, Herceg A, Douglas K, Tongs J, Bookallil M. Increasing Pap smear rates at an urban Aboriginal Community Controlled Health Service through translational research and continuous quality improvement. Aust J Prim Health. 2015;21(4):417-22.

Link: https://www.ncbi.nlm.nih.gov/pubmed/25703868

NPM: 1: Well-Woman Visit
Intervention Components (click on component to see a list of all articles that use that intervention): PATIENT/CONSUMER, Patient Reminder/Invitation, Educational Material, PROVIDER/PRACTICE, Provider Reminder/Recall Systems, Quality Improvement/Practice-Wide Intervention, Designated Clinic/Extended Hours, Female Provider

Intervention Results:

Significant increase in Pap smear rate in study year compared with previous years (t(3)=10.25. p=.002). Increase stayed significantly higher at 10 months follow-up (t(50)= -3.221, p=.002)

Bastani R, Berman BA, Belin TR, et al. Increasing cervical cancer screening among underserved women in a large urban county health system: can it be done? What does it take? Med Care. 2002;40(10):891-907.

Link: https://www.ncbi.nlm.nih.gov/pubmed/12395023

NPM: 1: Well-Woman Visit
Intervention Components (click on component to see a list of all articles that use that intervention): PATIENT/CONSUMER, Educational Material, PROVIDER/PRACTICE, Provider Education, Provider Audit/Practice Audit, Quality Improvement/Practice-Wide Intervention, Designated Clinic/Extended Hours

Intervention Results:

  • At Hospital level, increase (10.6%) from baseline to intervention years in intervention group compared with decline (-0.1%) in control group (p<.05 for difference in change scores).
  • Increase in screening rates at Comprehensive Health Center (CHC) 8.6% compared with 6.6% decline in control group (p<.05 for difference in change scores).
  • No intervention effect at the Public Health Center (PHC) level.
  • After adjusting for case-mix, significant intervention effect at Hospital (OR=3.06; 95% CI: 2.07-4.54) and CHC (OR=2.34, 95% CI: 1.05-5.23) but not at PHC level (OR=1.00. 95% CI: 0.63-1.56)

Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Sheinfeld Gorin S. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine, 2015;33(9):1223-1229.

Link: http://europepmc.org/abstract/med/25448095

NPM: 1: Well-Woman Visit
Intervention Components (click on component to see a list of all articles that use that intervention): PROVIDER/PRACTICE, Provider Education, Quality Improvement/Practice-Wide Intervention, Provider Incentives (Maintenance of Certification)

Intervention Results:

  • Significantly higher rate of HPV vaccine initiation at intervention practices during the active intervention period compared to control practices (OR=1.6; 95% CI=1.1, 2.2; P<.01).
  • Significant differences not sustained during the post-intervention period.
   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.